BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 28411478)

  • 1. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
    Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
    Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive doxorubicin-loaded polymeric nanocomplex based on β-cyclodextrin for liver cancer-targeted therapy.
    Yang T; Du G; Cui Y; Yu R; Hua C; Tian W; Zhang Y
    Int J Nanomedicine; 2019; 14():1997-2010. PubMed ID: 30962684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma.
    Zhang C; An T; Wang D; Wan G; Zhang M; Wang H; Zhang S; Li R; Yang X; Wang Y
    J Control Release; 2016 Mar; 226():193-204. PubMed ID: 26896737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.
    Wang D; Zhang S; Zhang T; Wan G; Chen B; Xiong Q; Zhang J; Zhang W; Wang Y
    Int J Nanomedicine; 2017; 12():8649-8670. PubMed ID: 29255359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core-shell nanoparticles based on pullulan and poly(β-amino) ester for hepatoma-targeted codelivery of gene and chemotherapy agent.
    Liu Y; Wang Y; Zhang C; Zhou P; Liu Y; An T; Sun D; Zhang N; Wang Y
    ACS Appl Mater Interfaces; 2014; 6(21):18712-20. PubMed ID: 25289563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
    Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N
    Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Cyclodextrin-modified hyaluronic acid-based supramolecular self-assemblies for pH- and esterase- dual-responsive drug delivery.
    Bai Y; Liu CP; Chen D; Liu CF; Zhuo LH; Li H; Wang C; Bu HT; Tian W
    Carbohydr Polym; 2020 Oct; 246():116654. PubMed ID: 32747286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchically Self-Assembled Supramolecular Host-Guest Delivery System for Drug Resistant Cancer Therapy.
    Cheng H; Fan X; Wang X; Ye E; Loh XJ; Li Z; Wu YL
    Biomacromolecules; 2018 Jun; 19(6):1926-1938. PubMed ID: 29350902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy.
    Lee SY; Ko SH; Shim JS; Kim DD; Cho HJ
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36628-36640. PubMed ID: 30298719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
    Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
    Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
    Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
    Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy.
    Mousazadeh H; Bonabi E; Zarghami N
    Carbohydr Polym; 2022 Jan; 276():118747. PubMed ID: 34823779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin.
    Teran-Saavedra NG; Sarabia-Sainz JA; Velázquez-Contreras EF; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.